Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-23

Clinical Trial Update: RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares adding highly-purified cytotoxic T lymphocytes to radiofrequency ablation versus radiofrequency ablation alone for recurrent h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Highly Purified CTL (Cytotoxic T Lymphocytes)

Snippet

Sponsor: Ming Kuang | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN